In gynaecological malignancies, IDO expression was detected in cervical, endometrial, and ovarian cancers with a high rate of positivity, although a very limited number of samples were analysed in prior studies (Sedlmayr et al, 2003; Uyttenhove et al, 2003). This evidence concerns the gene IDO1 and ovarian cancer.